14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.22 $6.22 Friday, 27th Jan 2023 LJPC stock ended at $6.22. During the day the stock fluctuated 0% from a day low at $6.22 to a day high of $6.22.
90 days $6.22 $6.22
52 weeks $3.07 $6.24

Historical La Jolla Pharmaceutical Company prices

Date Open High Low Close Volume
Nov 14, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 11, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 10, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 09, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 08, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 07, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 04, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 03, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 02, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 01, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 31, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 28, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 27, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 26, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 25, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 24, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 21, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 20, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 19, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 18, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 17, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 14, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 13, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 12, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 11, 2022 $6.22 $6.22 $6.22 $6.22 0
Click to get the best stock tips daily for free!

About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age ... LJPC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT